COVID-19 Impact on Global Recombinant Glycosylated Protein, Market Insights and Forecast to 2026
- BMR3903648
- 115 Pages
- June 2020
- Healthcare
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Recombinant Glycosylated Protein industry.
Based on our recent survey, we have several different scenarios about the Recombinant Glycosylated Protein YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Recombinant Glycosylated Protein will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Recombinant Glycosylated Protein market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Recombinant Glycosylated Protein market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Recombinant Glycosylated Protein market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Recombinant Glycosylated Protein market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Recombinant Glycosylated Protein market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Recombinant Glycosylated Protein market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Recombinant Glycosylated Protein market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Recombinant Glycosylated Protein market.
The following manufacturers are covered in this report:
Novartis International AG
Hospira Inc
Celltrion Pharma Inc
Biocon Limited
Teva Pharmaceutical Industries Ltd
...
Recombinant Glycosylated Protein Breakdown Data by Type
Insulin
rHGH
Interferon
Recombinant Glycosylated Protein Breakdown Data by Application
Blood & Oncology Diseases
Chronic Diseases
Others
1.1 Recombinant Glycosylated Protein Product Introduction
1.2 Market Segments
1.3 Key Recombinant Glycosylated Protein Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Recombinant Glycosylated Protein Market Size Growth Rate by Type
1.4.2 Insulin
1.4.3 rHGH
1.4.4 Interferon
1.5 Market by Application
1.5.1 Global Recombinant Glycosylated Protein Market Size Growth Rate by Application
1.5.2 Blood & Oncology Diseases
1.5.3 Chronic Diseases
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Recombinant Glycosylated Protein Industry Impact
1.6.1 How the Covid-19 is Affecting the Recombinant Glycosylated Protein Industry
1.6.1.1 Recombinant Glycosylated Protein Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Recombinant Glycosylated Protein Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Recombinant Glycosylated Protein Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Recombinant Glycosylated Protein Market Size Estimates and Forecasts
2.1.1 Global Recombinant Glycosylated Protein Revenue 2015-2026
2.1.2 Global Recombinant Glycosylated Protein Sales 2015-2026
2.2 Recombinant Glycosylated Protein Market Size by Region: 2020 Versus 2026
2.2.1 Global Recombinant Glycosylated Protein Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Recombinant Glycosylated Protein Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Recombinant Glycosylated Protein Competitor Landscape by Players
3.1 Recombinant Glycosylated Protein Sales by Manufacturers
3.1.1 Recombinant Glycosylated Protein Sales by Manufacturers (2015-2020)
3.1.2 Recombinant Glycosylated Protein Sales Market Share by Manufacturers (2015-2020)
3.2 Recombinant Glycosylated Protein Revenue by Manufacturers
3.2.1 Recombinant Glycosylated Protein Revenue by Manufacturers (2015-2020)
3.2.2 Recombinant Glycosylated Protein Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Recombinant Glycosylated Protein Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Recombinant Glycosylated Protein Revenue in 2019
3.2.5 Global Recombinant Glycosylated Protein Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Recombinant Glycosylated Protein Price by Manufacturers
3.4 Recombinant Glycosylated Protein Manufacturing Base Distribution, Product Types
3.4.1 Recombinant Glycosylated Protein Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Recombinant Glycosylated Protein Product Type
3.4.3 Date of International Manufacturers Enter into Recombinant Glycosylated Protein Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Recombinant Glycosylated Protein Market Size by Type (2015-2020)
4.1.1 Global Recombinant Glycosylated Protein Sales by Type (2015-2020)
4.1.2 Global Recombinant Glycosylated Protein Revenue by Type (2015-2020)
4.1.3 Recombinant Glycosylated Protein Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Recombinant Glycosylated Protein Market Size Forecast by Type (2021-2026)
4.2.1 Global Recombinant Glycosylated Protein Sales Forecast by Type (2021-2026)
4.2.2 Global Recombinant Glycosylated Protein Revenue Forecast by Type (2021-2026)
4.2.3 Recombinant Glycosylated Protein Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Recombinant Glycosylated Protein Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Recombinant Glycosylated Protein Market Size by Application (2015-2020)
5.1.1 Global Recombinant Glycosylated Protein Sales by Application (2015-2020)
5.1.2 Global Recombinant Glycosylated Protein Revenue by Application (2015-2020)
5.1.3 Recombinant Glycosylated Protein Price by Application (2015-2020)
5.2 Recombinant Glycosylated Protein Market Size Forecast by Application (2021-2026)
5.2.1 Global Recombinant Glycosylated Protein Sales Forecast by Application (2021-2026)
5.2.2 Global Recombinant Glycosylated Protein Revenue Forecast by Application (2021-2026)
5.2.3 Global Recombinant Glycosylated Protein Price Forecast by Application (2021-2026)
6 North America
6.1 North America Recombinant Glycosylated Protein by Country
6.1.1 North America Recombinant Glycosylated Protein Sales by Country
6.1.2 North America Recombinant Glycosylated Protein Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Recombinant Glycosylated Protein Market Facts & Figures by Type
6.3 North America Recombinant Glycosylated Protein Market Facts & Figures by Application
7 Europe
7.1 Europe Recombinant Glycosylated Protein by Country
7.1.1 Europe Recombinant Glycosylated Protein Sales by Country
7.1.2 Europe Recombinant Glycosylated Protein Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Recombinant Glycosylated Protein Market Facts & Figures by Type
7.3 Europe Recombinant Glycosylated Protein Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Recombinant Glycosylated Protein by Region
8.1.1 Asia Pacific Recombinant Glycosylated Protein Sales by Region
8.1.2 Asia Pacific Recombinant Glycosylated Protein Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Recombinant Glycosylated Protein Market Facts & Figures by Type
8.3 Asia Pacific Recombinant Glycosylated Protein Market Facts & Figures by Application
9 Latin America
9.1 Latin America Recombinant Glycosylated Protein by Country
9.1.1 Latin America Recombinant Glycosylated Protein Sales by Country
9.1.2 Latin America Recombinant Glycosylated Protein Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Recombinant Glycosylated Protein Market Facts & Figures by Type
9.3 Central & South America Recombinant Glycosylated Protein Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Recombinant Glycosylated Protein by Country
10.1.1 Middle East and Africa Recombinant Glycosylated Protein Sales by Country
10.1.2 Middle East and Africa Recombinant Glycosylated Protein Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Recombinant Glycosylated Protein Market Facts & Figures by Type
10.3 Middle East and Africa Recombinant Glycosylated Protein Market Facts & Figures by Application
11 Company Profiles
11.1 Novartis International AG
11.1.1 Novartis International AG Corporation Information
11.1.2 Novartis International AG Description, Business Overview and Total Revenue
11.1.3 Novartis International AG Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis International AG Recombinant Glycosylated Protein Products Offered
11.1.5 Novartis International AG Recent Development
11.2 Hospira Inc
11.2.1 Hospira Inc Corporation Information
11.2.2 Hospira Inc Description, Business Overview and Total Revenue
11.2.3 Hospira Inc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Hospira Inc Recombinant Glycosylated Protein Products Offered
11.2.5 Hospira Inc Recent Development
11.3 Celltrion Pharma Inc
11.3.1 Celltrion Pharma Inc Corporation Information
11.3.2 Celltrion Pharma Inc Description, Business Overview and Total Revenue
11.3.3 Celltrion Pharma Inc Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Celltrion Pharma Inc Recombinant Glycosylated Protein Products Offered
11.3.5 Celltrion Pharma Inc Recent Development
11.4 Biocon Limited
11.4.1 Biocon Limited Corporation Information
11.4.2 Biocon Limited Description, Business Overview and Total Revenue
11.4.3 Biocon Limited Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Biocon Limited Recombinant Glycosylated Protein Products Offered
11.4.5 Biocon Limited Recent Development
11.5 Teva Pharmaceutical Industries Ltd
11.5.1 Teva Pharmaceutical Industries Ltd Corporation Information
11.5.2 Teva Pharmaceutical Industries Ltd Description, Business Overview and Total Revenue
11.5.3 Teva Pharmaceutical Industries Ltd Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Teva Pharmaceutical Industries Ltd Recombinant Glycosylated Protein Products Offered
11.5.5 Teva Pharmaceutical Industries Ltd Recent Development
11.1 Novartis International AG
11.1.1 Novartis International AG Corporation Information
11.1.2 Novartis International AG Description, Business Overview and Total Revenue
11.1.3 Novartis International AG Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis International AG Recombinant Glycosylated Protein Products Offered
11.1.5 Novartis International AG Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Recombinant Glycosylated Protein Market Estimates and Projections by Region
12.1.1 Global Recombinant Glycosylated Protein Sales Forecast by Regions 2021-2026
12.1.2 Global Recombinant Glycosylated Protein Revenue Forecast by Regions 2021-2026
12.2 North America Recombinant Glycosylated Protein Market Size Forecast (2021-2026)
12.2.1 North America: Recombinant Glycosylated Protein Sales Forecast (2021-2026)
12.2.2 North America: Recombinant Glycosylated Protein Revenue Forecast (2021-2026)
12.2.3 North America: Recombinant Glycosylated Protein Market Size Forecast by Country (2021-2026)
12.3 Europe Recombinant Glycosylated Protein Market Size Forecast (2021-2026)
12.3.1 Europe: Recombinant Glycosylated Protein Sales Forecast (2021-2026)
12.3.2 Europe: Recombinant Glycosylated Protein Revenue Forecast (2021-2026)
12.3.3 Europe: Recombinant Glycosylated Protein Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Recombinant Glycosylated Protein Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Recombinant Glycosylated Protein Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Recombinant Glycosylated Protein Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Recombinant Glycosylated Protein Market Size Forecast by Region (2021-2026)
12.5 Latin America Recombinant Glycosylated Protein Market Size Forecast (2021-2026)
12.5.1 Latin America: Recombinant Glycosylated Protein Sales Forecast (2021-2026)
12.5.2 Latin America: Recombinant Glycosylated Protein Revenue Forecast (2021-2026)
12.5.3 Latin America: Recombinant Glycosylated Protein Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Recombinant Glycosylated Protein Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Recombinant Glycosylated Protein Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Recombinant Glycosylated Protein Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Recombinant Glycosylated Protein Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Recombinant Glycosylated Protein Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Recombinant Glycosylated Protein Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
Table 1. Recombinant Glycosylated Protein Market Segments
Table 2. Ranking of Global Top Recombinant Glycosylated Protein Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Recombinant Glycosylated Protein Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Insulin
Table 5. Major Manufacturers of rHGH
Table 6. Major Manufacturers of Interferon
Table 7. COVID-19 Impact Global Market: (Four Recombinant Glycosylated Protein Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Recombinant Glycosylated Protein Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Recombinant Glycosylated Protein Players to Combat Covid-19 Impact
Table 12. Global Recombinant Glycosylated Protein Market Size Growth Rate by Application 2020-2026 (K MT)
Table 13. Global Recombinant Glycosylated Protein Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 14. Global Recombinant Glycosylated Protein Sales by Regions 2015-2020 (K MT)
Table 15. Global Recombinant Glycosylated Protein Sales Market Share by Regions (2015-2020)
Table 16. Global Recombinant Glycosylated Protein Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Recombinant Glycosylated Protein Sales by Manufacturers (2015-2020) (K MT)
Table 18. Global Recombinant Glycosylated Protein Sales Share by Manufacturers (2015-2020)
Table 19. Global Recombinant Glycosylated Protein Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Recombinant Glycosylated Protein by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Glycosylated Protein as of 2019)
Table 21. Recombinant Glycosylated Protein Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Recombinant Glycosylated Protein Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Recombinant Glycosylated Protein Price (2015-2020) (USD/MT)
Table 24. Recombinant Glycosylated Protein Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Recombinant Glycosylated Protein Product Type
Table 26. Date of International Manufacturers Enter into Recombinant Glycosylated Protein Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Recombinant Glycosylated Protein Sales by Type (2015-2020) (K MT)
Table 29. Global Recombinant Glycosylated Protein Sales Share by Type (2015-2020)
Table 30. Global Recombinant Glycosylated Protein Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Recombinant Glycosylated Protein Revenue Share by Type (2015-2020)
Table 32. Recombinant Glycosylated Protein Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 33. Global Recombinant Glycosylated Protein Sales by Application (2015-2020) (K MT)
Table 34. Global Recombinant Glycosylated Protein Sales Share by Application (2015-2020)
Table 35. North America Recombinant Glycosylated Protein Sales by Country (2015-2020) (K MT)
Table 36. North America Recombinant Glycosylated Protein Sales Market Share by Country (2015-2020)
Table 37. North America Recombinant Glycosylated Protein Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Recombinant Glycosylated Protein Revenue Market Share by Country (2015-2020)
Table 39. North America Recombinant Glycosylated Protein Sales by Type (2015-2020) (K MT)
Table 40. North America Recombinant Glycosylated Protein Sales Market Share by Type (2015-2020)
Table 41. North America Recombinant Glycosylated Protein Sales by Application (2015-2020) (K MT)
Table 42. North America Recombinant Glycosylated Protein Sales Market Share by Application (2015-2020)
Table 43. Europe Recombinant Glycosylated Protein Sales by Country (2015-2020) (K MT)
Table 44. Europe Recombinant Glycosylated Protein Sales Market Share by Country (2015-2020)
Table 45. Europe Recombinant Glycosylated Protein Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Recombinant Glycosylated Protein Revenue Market Share by Country (2015-2020)
Table 47. Europe Recombinant Glycosylated Protein Sales by Type (2015-2020) (K MT)
Table 48. Europe Recombinant Glycosylated Protein Sales Market Share by Type (2015-2020)
Table 49. Europe Recombinant Glycosylated Protein Sales by Application (2015-2020) (K MT)
Table 50. Europe Recombinant Glycosylated Protein Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Recombinant Glycosylated Protein Sales by Region (2015-2020) (K MT)
Table 52. Asia Pacific Recombinant Glycosylated Protein Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Recombinant Glycosylated Protein Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Recombinant Glycosylated Protein Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Recombinant Glycosylated Protein Sales by Type (2015-2020) (K MT)
Table 56. Asia Pacific Recombinant Glycosylated Protein Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Recombinant Glycosylated Protein Sales by Application (2015-2020) (K MT)
Table 58. Asia Pacific Recombinant Glycosylated Protein Sales Market Share by Application (2015-2020)
Table 59. Latin America Recombinant Glycosylated Protein Sales by Country (2015-2020) (K MT)
Table 60. Latin America Recombinant Glycosylated Protein Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Recombinant Glycosylated Protein Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Recombinant Glycosylated Protein Revenue Market Share by Country (2015-2020)
Table 63. Latin America Recombinant Glycosylated Protein Sales by Type (2015-2020) (K MT)
Table 64. Latin America Recombinant Glycosylated Protein Sales Market Share by Type (2015-2020)
Table 65. Latin America Recombinant Glycosylated Protein Sales by Application (2015-2020) (K MT)
Table 66. Latin America Recombinant Glycosylated Protein Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Recombinant Glycosylated Protein Sales by Country (2015-2020) (K MT)
Table 68. Middle East and Africa Recombinant Glycosylated Protein Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Recombinant Glycosylated Protein Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Recombinant Glycosylated Protein Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Recombinant Glycosylated Protein Sales by Type (2015-2020) (K MT)
Table 72. Middle East and Africa Recombinant Glycosylated Protein Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Recombinant Glycosylated Protein Sales by Application (2015-2020) (K MT)
Table 74. Middle East and Africa Recombinant Glycosylated Protein Sales Market Share by Application (2015-2020)
Table 75. Novartis International AG Corporation Information
Table 76. Novartis International AG Description and Major Businesses
Table 77. Novartis International AG Recombinant Glycosylated Protein Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Novartis International AG Product
Table 79. Novartis International AG Recent Development
Table 80. Hospira Inc Corporation Information
Table 81. Hospira Inc Description and Major Businesses
Table 82. Hospira Inc Recombinant Glycosylated Protein Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Hospira Inc Product
Table 84. Hospira Inc Recent Development
Table 85. Celltrion Pharma Inc Corporation Information
Table 86. Celltrion Pharma Inc Description and Major Businesses
Table 87. Celltrion Pharma Inc Recombinant Glycosylated Protein Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Celltrion Pharma Inc Product
Table 89. Celltrion Pharma Inc Recent Development
Table 90. Biocon Limited Corporation Information
Table 91. Biocon Limited Description and Major Businesses
Table 92. Biocon Limited Recombinant Glycosylated Protein Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Biocon Limited Product
Table 94. Biocon Limited Recent Development
Table 95. Teva Pharmaceutical Industries Ltd Corporation Information
Table 96. Teva Pharmaceutical Industries Ltd Description and Major Businesses
Table 97. Teva Pharmaceutical Industries Ltd Recombinant Glycosylated Protein Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Teva Pharmaceutical Industries Ltd Product
Table 99. Teva Pharmaceutical Industries Ltd Recent Development
Table 100. Global Recombinant Glycosylated Protein Sales Forecast by Regions (2021-2026) (K MT)
Table 101. Global Recombinant Glycosylated Protein Sales Market Share Forecast by Regions (2021-2026)
Table 102. Global Recombinant Glycosylated Protein Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 103. Global Recombinant Glycosylated Protein Revenue Market Share Forecast by Regions (2021-2026)
Table 104. North America: Recombinant Glycosylated Protein Sales Forecast by Country (2021-2026) (K MT)
Table 105. North America: Recombinant Glycosylated Protein Revenue Forecast by Country (2021-2026) (US$ Million)
Table 106. Europe: Recombinant Glycosylated Protein Sales Forecast by Country (2021-2026) (K MT)
Table 107. Europe: Recombinant Glycosylated Protein Revenue Forecast by Country (2021-2026) (US$ Million)
Table 108. Asia Pacific: Recombinant Glycosylated Protein Sales Forecast by Region (2021-2026) (K MT)
Table 109. Asia Pacific: Recombinant Glycosylated Protein Revenue Forecast by Region (2021-2026) (US$ Million)
Table 110. Latin America: Recombinant Glycosylated Protein Sales Forecast by Country (2021-2026) (K MT)
Table 111. Latin America: Recombinant Glycosylated Protein Revenue Forecast by Country (2021-2026) (US$ Million)
Table 112. Middle East and Africa: Recombinant Glycosylated Protein Sales Forecast by Country (2021-2026) (K MT)
Table 113. Middle East and Africa: Recombinant Glycosylated Protein Revenue Forecast by Country (2021-2026) (US$ Million)
Table 114. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 115. Key Challenges
Table 116. Market Risks
Table 117. Main Points Interviewed from Key Recombinant Glycosylated Protein Players
Table 118. Recombinant Glycosylated Protein Customers List
Table 119. Recombinant Glycosylated Protein Distributors List
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Recombinant Glycosylated Protein Product Picture
Figure 2. Global Recombinant Glycosylated Protein Sales Market Share by Type in 2020 & 2026
Figure 3. Insulin Product Picture
Figure 4. rHGH Product Picture
Figure 5. Interferon Product Picture
Figure 6. Global Recombinant Glycosylated Protein Sales Market Share by Application in 2020 & 2026
Figure 7. Blood & Oncology Diseases
Figure 8. Chronic Diseases
Figure 9. Others
Figure 10. Recombinant Glycosylated Protein Report Years Considered
Figure 11. Global Recombinant Glycosylated Protein Market Size 2015-2026 (US$ Million)
Figure 12. Global Recombinant Glycosylated Protein Sales 2015-2026 (K MT)
Figure 13. Global Recombinant Glycosylated Protein Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Recombinant Glycosylated Protein Sales Market Share by Region (2015-2020)
Figure 15. Global Recombinant Glycosylated Protein Sales Market Share by Region in 2019
Figure 16. Global Recombinant Glycosylated Protein Revenue Market Share by Region (2015-2020)
Figure 17. Global Recombinant Glycosylated Protein Revenue Market Share by Region in 2019
Figure 18. Global Recombinant Glycosylated Protein Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Recombinant Glycosylated Protein Revenue in 2019
Figure 20. Recombinant Glycosylated Protein Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Recombinant Glycosylated Protein Sales Market Share by Type (2015-2020)
Figure 22. Global Recombinant Glycosylated Protein Sales Market Share by Type in 2019
Figure 23. Global Recombinant Glycosylated Protein Revenue Market Share by Type (2015-2020)
Figure 24. Global Recombinant Glycosylated Protein Revenue Market Share by Type in 2019
Figure 25. Global Recombinant Glycosylated Protein Market Share by Price Range (2015-2020)
Figure 26. Global Recombinant Glycosylated Protein Sales Market Share by Application (2015-2020)
Figure 27. Global Recombinant Glycosylated Protein Sales Market Share by Application in 2019
Figure 28. Global Recombinant Glycosylated Protein Revenue Market Share by Application (2015-2020)
Figure 29. Global Recombinant Glycosylated Protein Revenue Market Share by Application in 2019
Figure 30. North America Recombinant Glycosylated Protein Sales Growth Rate 2015-2020 (K MT)
Figure 31. North America Recombinant Glycosylated Protein Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Recombinant Glycosylated Protein Sales Market Share by Country in 2019
Figure 33. North America Recombinant Glycosylated Protein Revenue Market Share by Country in 2019
Figure 34. U.S. Recombinant Glycosylated Protein Sales Growth Rate (2015-2020) (K MT)
Figure 35. U.S. Recombinant Glycosylated Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Recombinant Glycosylated Protein Sales Growth Rate (2015-2020) (K MT)
Figure 37. Canada Recombinant Glycosylated Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Recombinant Glycosylated Protein Market Share by Type in 2019
Figure 39. North America Recombinant Glycosylated Protein Market Share by Application in 2019
Figure 40. Europe Recombinant Glycosylated Protein Sales Growth Rate 2015-2020 (K MT)
Figure 41. Europe Recombinant Glycosylated Protein Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Recombinant Glycosylated Protein Sales Market Share by Country in 2019
Figure 43. Europe Recombinant Glycosylated Protein Revenue Market Share by Country in 2019
Figure 44. Germany Recombinant Glycosylated Protein Sales Growth Rate (2015-2020) (K MT)
Figure 45. Germany Recombinant Glycosylated Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Recombinant Glycosylated Protein Sales Growth Rate (2015-2020) (K MT)
Figure 47. France Recombinant Glycosylated Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Recombinant Glycosylated Protein Sales Growth Rate (2015-2020) (K MT)
Figure 49. U.K. Recombinant Glycosylated Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Recombinant Glycosylated Protein Sales Growth Rate (2015-2020) (K MT)
Figure 51. Italy Recombinant Glycosylated Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Recombinant Glycosylated Protein Sales Growth Rate (2015-2020) (K MT)
Figure 53. Russia Recombinant Glycosylated Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Recombinant Glycosylated Protein Market Share by Type in 2019
Figure 55. Europe Recombinant Glycosylated Protein Market Share by Application in 2019
Figure 56. Asia Pacific Recombinant Glycosylated Protein Sales Growth Rate 2015-2020 (K MT)
Figure 57. Asia Pacific Recombinant Glycosylated Protein Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Recombinant Glycosylated Protein Sales Market Share by Region in 2019
Figure 59. Asia Pacific Recombinant Glycosylated Protein Revenue Market Share by Region in 2019
Figure 60. China Recombinant Glycosylated Protein Sales Growth Rate (2015-2020) (K MT)
Figure 61. China Recombinant Glycosylated Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Recombinant Glycosylated Protein Sales Growth Rate (2015-2020) (K MT)
Figure 63. Japan Recombinant Glycosylated Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Recombinant Glycosylated Protein Sales Growth Rate (2015-2020) (K MT)
Figure 65. South Korea Recombinant Glycosylated Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Recombinant Glycosylated Protein Sales Growth Rate (2015-2020) (K MT)
Figure 67. India Recombinant Glycosylated Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Recombinant Glycosylated Protein Sales Growth Rate (2015-2020) (K MT)
Figure 69. Australia Recombinant Glycosylated Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Recombinant Glycosylated Protein Sales Growth Rate (2015-2020) (K MT)
Figure 71. Taiwan Recombinant Glycosylated Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Recombinant Glycosylated Protein Sales Growth Rate (2015-2020) (K MT)
Figure 73. Indonesia Recombinant Glycosylated Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Recombinant Glycosylated Protein Sales Growth Rate (2015-2020) (K MT)
Figure 75. Thailand Recombinant Glycosylated Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Recombinant Glycosylated Protein Sales Growth Rate (2015-2020) (K MT)
Figure 77. Malaysia Recombinant Glycosylated Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Recombinant Glycosylated Protein Sales Growth Rate (2015-2020) (K MT)
Figure 79. Philippines Recombinant Glycosylated Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Recombinant Glycosylated Protein Sales Growth Rate (2015-2020) (K MT)
Figure 81. Vietnam Recombinant Glycosylated Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Recombinant Glycosylated Protein Market Share by Type in 2019
Figure 83. Asia Pacific Recombinant Glycosylated Protein Market Share by Application in 2019
Figure 84. Latin America Recombinant Glycosylated Protein Sales Growth Rate 2015-2020 (K MT)
Figure 85. Latin America Recombinant Glycosylated Protein Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Recombinant Glycosylated Protein Sales Market Share by Country in 2019
Figure 87. Latin America Recombinant Glycosylated Protein Revenue Market Share by Country in 2019
Figure 88. Mexico Recombinant Glycosylated Protein Sales Growth Rate (2015-2020) (K MT)
Figure 89. Mexico Recombinant Glycosylated Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Recombinant Glycosylated Protein Sales Growth Rate (2015-2020) (K MT)
Figure 91. Brazil Recombinant Glycosylated Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Recombinant Glycosylated Protein Sales Growth Rate (2015-2020) (K MT)
Figure 93. Argentina Recombinant Glycosylated Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Recombinant Glycosylated Protein Market Share by Type in 2019
Figure 95. Latin America Recombinant Glycosylated Protein Market Share by Application in 2019
Figure 96. Middle East and Africa Recombinant Glycosylated Protein Sales Growth Rate 2015-2020 (K MT)
Figure 97. Middle East and Africa Recombinant Glycosylated Protein Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Recombinant Glycosylated Protein Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Recombinant Glycosylated Protein Revenue Market Share by Country in 2019
Figure 100. Turkey Recombinant Glycosylated Protein Sales Growth Rate (2015-2020) (K MT)
Figure 101. Turkey Recombinant Glycosylated Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Recombinant Glycosylated Protein Sales Growth Rate (2015-2020) (K MT)
Figure 103. Saudi Arabia Recombinant Glycosylated Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Recombinant Glycosylated Protein Sales Growth Rate (2015-2020) (K MT)
Figure 105. U.A.E Recombinant Glycosylated Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Recombinant Glycosylated Protein Market Share by Type in 2019
Figure 107. Middle East and Africa Recombinant Glycosylated Protein Market Share by Application in 2019
Figure 108. Novartis International AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Hospira Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Celltrion Pharma Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Biocon Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Teva Pharmaceutical Industries Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. North America Recombinant Glycosylated Protein Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. North America Recombinant Glycosylated Protein Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Europe Recombinant Glycosylated Protein Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Europe Recombinant Glycosylated Protein Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Asia Pacific Recombinant Glycosylated Protein Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 118. Asia Pacific Recombinant Glycosylated Protein Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Latin America Recombinant Glycosylated Protein Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 120. Latin America Recombinant Glycosylated Protein Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Middle East and Africa Recombinant Glycosylated Protein Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 122. Middle East and Africa Recombinant Glycosylated Protein Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Porter's Five Forces Analysis
Figure 124. Channels of Distribution
Figure 125. Distributors Profiles
Figure 126. Bottom-up and Top-down Approaches for This Report
Figure 127. Data Triangulation
Figure 128. Key Executives Interviewed
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
